A 20 year old female was diagnosed with acute myeloid leukaemia & underwent allogenic stem cell transplantation a year ago. In her follow up visit, she has manifestations of chronic graft-versus-host disease but otherwise is doing well & has no evidence of recurrence. Which of the following vaccines should not be administered to this patient at this point of time?

## Core Concept
The question revolves around the management of a patient with a history of allogenic stem cell transplantation now experiencing chronic graft-versus-host disease (cGVHD). A critical aspect of post-transplant care is the vaccination strategy to prevent infections. However, the immune status of these patients, especially those with cGVHD, can affect the safety and efficacy of live vaccines.

## Why the Correct Answer is Right
The correct answer, , refers to live attenuated vaccines. Patients with chronic graft-versus-host disease are immunocompromised due to their underlying condition and the immunosuppressive therapy they often receive to manage cGVHD. Live vaccines, which contain weakened but live pathogens, can pose a risk to these patients because their compromised immune systems may not be able to handle even weakened pathogens, potentially leading to vaccine-strain infections.

## Why Each Wrong Option is Incorrect
- **Option A:** This option likely refers to inactivated or killed vaccines, which are generally safe for immunocompromised patients, including those with cGVHD. These vaccines do not contain live pathogens and thus cannot cause the disease itself.
- **Option B:** This could refer to another type of vaccine that is not live, such as a subunit vaccine or a conjugate vaccine, which are also safe for use in immunocompromised patients.
- **Option D:** Similarly, this might refer to a vaccine that is not a live vaccine, such as a polysaccharide vaccine or a recombinant vaccine, which are considered safe for patients with compromised immune systems.

## Clinical Pearl / High-Yield Fact
A crucial point to remember is that patients with cGVHD should avoid live vaccines due to the risk of vaccine-associated infections. Inactivated vaccines are preferred in these patients to ensure safety while still providing immune protection against specific pathogens. Common live vaccines that should be avoided include the MMR (measles, mumps, and rubella) vaccine, the varicella vaccine, and the live attenuated influenza vaccine.

**Correct Answer: C. Live attenuated vaccines**

✓ Correct Answer: C. Measles, mumps, and rubella